Bulletin du Cancer
MENUIndividualized anticancer therapies: which regulatory guidelines? Volume 95, issue 10, octobre 2008
Authors
Centre des innovations thérapeutiques en oncologie et hématologie, centre hospitalier universitaire Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris
- Key words: guidelines, biomarkers
- DOI : 10.1684/bdc.2008.0733
- Page(s) : 985-8
- Published in: 2008
In this review, we will summarize the guidelines on the evaluation of anticancer medicinal products in man and definitions for genomic biomarkers (FDA validated), pharmacogenomics, pharmacogenetics, genomic data and sample coding categories.